Musculoskeletal, Soft Tissue, and Bladder presets as well as enhanced measurement calculations highlight continuous innovation of Vave’s whole-body single probe
SAN JOSE, Calif., July 8, 2025 /PRNewswire/ — Vave Health, a leader in wireless, whole-body handheld ultrasound solutions, proudly announces a new wave of feature enhancements designed to further empower healthcare professionals. With these updates, Vave Health continues its mission to bring affordable, ultra-portable imaging technology that is straightforward and accessible for all.
Launched in March 2025, the Universal Probe is designed for continuous improvement, with quarterly updates delivered at no additional cost to health care professionals utilizing the device.
“Vave prides itself on lifetime value of the product, so what you pay up-front is what it costs for the probe. There is no subscription model, and all new updates are pushed via software at no cost to the end user,” states Amin Nikoozadeh, Founder and CEO of Vave Health.
Universal Probe: Enhanced Diagnostic Tools
The Universal Probe now boasts several cutting-edge updates to enhance its diagnostic capabilities:
“At Vave, our mission is to equip all healthcare providers with the tools they need for the best patient care. We are proud that each release is driven by customer feedback and requests and we embrace a continuous improvement mindset,” says Renee Dversdal, Chief Medical Officer of Vave Health.
About Vave Health
Founded by a Stanford University Ph.D. specializing in imaging system miniaturization, Vave Health is dedicated to delivering high-quality diagnostic tools at the point of care. Our state-of-the-art, ultraportable solution is headquartered in San Jose, California, and is setting new standards in medical imaging technology and solutions.
For more information, please visit vavehealth.com
SOURCE Vave Health
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…
– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…
Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…
AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy cost containment…
NEW YORK, Jan. 30, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…
HENDERSON, Nev., Jan. 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national…